Status:

RECRUITING

Hypercapnia in Orthostatic Hypotension

Lead Sponsor:

University of Calgary

Conditions:

Orthostatic Hypotension

Neurogenic Orthostatic Hypotension

Eligibility:

All Genders

18-100 years

Phase:

NA

Brief Summary

The Autonomic (or "automatic") Nervous System (ANS) regulates internal processes, including control of heart rate and blood pressure (BP). When someone stands, and gravity tries to pull blood away fro...

Detailed Description

BACKGROUND: Regulation of tissue blood supply to vital organs such as the brain and heart is met in large part by local adjustment of the microvasculature (autoregulation) and autonomic nervous system...

Eligibility Criteria

Inclusion

  • Age ≥18 years
  • Male and Female
  • Non - smokers.
  • Able and willing to provide informed consent.
  • Ability to travel to Libin Cardiovascular Institute Autonomic Testing Lab at the University of Calgary, Calgary, AB.

Exclusion

  • Medical therapies or medications which could interfere with testing of autonomic function
  • Participants with somatization or severe anxiety symptoms will be excluded
  • Pregnant or breast-feeding females
  • Inability to tolerate mask for the duration of the study
  • Subjects who require portable oxygen at rest or with exercise
  • Subjects with chronic heart failure or severe pulmonary disease who are unable to climb one flight of stairs due to shortness of breath.
  • Presence of failure of other organ systems or systemic illness that can affect autonomic function or the participant's ability to cooperate. These include: dementia, alcohol and/or drug abuse, cerebrovascular disease, kidney or liver disease, surgical procedures where the nerves of the sympathetic nervous system have been cut.
  • Other factors which in the investigator's opinion would prevent the participant from completing the protocol, including poor compliance during previous studies.

Key Trial Info

Start Date :

March 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 31 2027

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT05295810

Start Date

March 1 2022

End Date

May 31 2027

Last Update

December 9 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Calgary

Calgary, Alberta, Canada